神经科威廉亚洲博彩公司

订阅

MedSci主页 / 所有栏目 / 神经科威廉亚洲博彩公司

穿支动脉粥样硬化病中国专家共识

2021-05-15 中国卒中学会 中国卒中杂志.2021.16(5):508-514.

动脉粥样硬化

穿支动脉粥样硬化病（BAD）是急性缺血性卒中的常见类型，，中国卒中学会脑小血管病分会成立专家组，结合国内外研究现状，撰写本专家共识，以指导BAD的临床诊治。专家组针对LSA和PPA供血区域BAD的发病

中文标题：

穿支动脉粥样硬化病中国专家共识

发布机构：

中国卒中学会

发布日期：

2021-05-15

简要介绍：

穿支动脉粥样硬化病（BAD）是急性缺血性卒中的常见类型，，中国卒中学会脑小血管病分会成立专家组，结合国内外研究现状，撰写本专家共识，以指导BAD的临床诊治。专家组针对LSA和PPA供血区域BAD的发病机制、临床表现及分类、辅助检查、诊断及治疗进行讨论，形成专家共识。

 

相关资料下载：
[AttachmentFileName(sort=1, fileName=穿支动脉粥样硬化病中国专家共识_门雪娇.pdf)] GetToolGuiderByIdResponse(projectId=1, id=971b51c002111e9d, title=穿支动脉粥样硬化病中国专家共识, enTitle=, guiderFrom=中国卒中杂志.2021.16(5):508-514., authorId=0, author=, summary=穿支动脉粥样硬化病（BAD）是急性缺血性卒中的常见类型，，中国卒中学会脑小血管病分会成立专家组，结合国内外研究现状，撰写本专家共识，以指导BAD的临床诊治。专家组针对LSA和PPA供血区域BAD的发病, cover=https://img.medsci.cn/202166/1622988350717_2020535.jpg, journalId=0, articlesId=null, associationId=1192, associationName=中国卒中学会, associationIntro=中国卒中学会, copyright=0, guiderPublishedTime=Sat May 15 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>穿支动脉粥样硬化病（BAD）是急性缺血性卒中的常见类型，，中国卒中学会脑小血管病分会成立专家组，结合国内外研究现状，撰写本专家共识，以指导BAD的临床诊治。专家组针对LSA和PPA供血区域BAD的发病机制、临床表现及分类、辅助检查、诊断及治疗进行讨论，形成专家共识。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=828, tagName=动脉粥样硬化)], categoryList=[CategoryDto(categoryId=17, categoryName=神经科, tenant=100), CategoryDto(categoryId=85, categoryName=威廉亚洲博彩公司 &解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=828, guiderKeyword=动脉粥样硬化, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=8329, appHits=404, showAppHits=0, pcHits=894, showPcHits=7925, likes=1, shares=50, comments=45, approvalStatus=1, publishedTime=Sun Jun 06 22:26:23 CST 2021, publishedTimeString=2021-05-15, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sun Jun 06 22:05:57 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 18:26:31 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=穿支动脉粥样硬化病中国专家共识_门雪娇.pdf)])
穿支动脉粥样硬化病中国专家共识_门雪娇.pdf
下载请点击：
评论区 (30)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1232142, encodeId=8db1123214277, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88ba5447974, createdName=ms7000001124466419, createdTime=Tue Jul 12 23:25:37 CST 2022, time=2022-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014685, encodeId=807b101468594, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/fa7de37cae58485d98eccde049d944c8/0c35dbfa935743f99a097a3af080f677.jpeg, createdBy=059a1620547, createdName=huihui0728, createdTime=Sun Sep 05 07:12:36 CST 2021, time=2021-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012410, encodeId=481610124104f, content=这些临床常用的很有必要的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210828/3c680d82017b40f098e56a34332210c7/2c87019ea1c04c1aa7e3c8d5ea2d41b5.jpg, createdBy=69b15553885, createdName=lotus蓉, createdTime=Sat Aug 28 21:55:56 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010327, encodeId=9c6f101032eef, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/fa7de37cae58485d98eccde049d944c8/0c35dbfa935743f99a097a3af080f677.jpeg, createdBy=059a1620547, createdName=huihui0728, createdTime=Sun Aug 22 15:51:34 CST 2021, time=2021-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006895, encodeId=a05910068954b, content=收益很大, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc035513110, createdName=霍, createdTime=Wed Aug 11 10:22:34 CST 2021, time=2021-08-11, status=1, ipAttribution=)]
    2022-07-12 ms7000001124466419

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1232142, encodeId=8db1123214277, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88ba5447974, createdName=ms7000001124466419, createdTime=Tue Jul 12 23:25:37 CST 2022, time=2022-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014685, encodeId=807b101468594, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/fa7de37cae58485d98eccde049d944c8/0c35dbfa935743f99a097a3af080f677.jpeg, createdBy=059a1620547, createdName=huihui0728, createdTime=Sun Sep 05 07:12:36 CST 2021, time=2021-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012410, encodeId=481610124104f, content=这些临床常用的很有必要的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210828/3c680d82017b40f098e56a34332210c7/2c87019ea1c04c1aa7e3c8d5ea2d41b5.jpg, createdBy=69b15553885, createdName=lotus蓉, createdTime=Sat Aug 28 21:55:56 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010327, encodeId=9c6f101032eef, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/fa7de37cae58485d98eccde049d944c8/0c35dbfa935743f99a097a3af080f677.jpeg, createdBy=059a1620547, createdName=huihui0728, createdTime=Sun Aug 22 15:51:34 CST 2021, time=2021-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006895, encodeId=a05910068954b, content=收益很大, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc035513110, createdName=霍, createdTime=Wed Aug 11 10:22:34 CST 2021, time=2021-08-11, status=1, ipAttribution=)]
    2021-09-05 huihui0728

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1232142, encodeId=8db1123214277, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88ba5447974, createdName=ms7000001124466419, createdTime=Tue Jul 12 23:25:37 CST 2022, time=2022-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014685, encodeId=807b101468594, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/fa7de37cae58485d98eccde049d944c8/0c35dbfa935743f99a097a3af080f677.jpeg, createdBy=059a1620547, createdName=huihui0728, createdTime=Sun Sep 05 07:12:36 CST 2021, time=2021-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012410, encodeId=481610124104f, content=这些临床常用的很有必要的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210828/3c680d82017b40f098e56a34332210c7/2c87019ea1c04c1aa7e3c8d5ea2d41b5.jpg, createdBy=69b15553885, createdName=lotus蓉, createdTime=Sat Aug 28 21:55:56 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010327, encodeId=9c6f101032eef, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/fa7de37cae58485d98eccde049d944c8/0c35dbfa935743f99a097a3af080f677.jpeg, createdBy=059a1620547, createdName=huihui0728, createdTime=Sun Aug 22 15:51:34 CST 2021, time=2021-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006895, encodeId=a05910068954b, content=收益很大, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc035513110, createdName=霍, createdTime=Wed Aug 11 10:22:34 CST 2021, time=2021-08-11, status=1, ipAttribution=)]
    2021-08-28 lotus蓉

    这些临床常用的很有必要的

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1232142, encodeId=8db1123214277, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88ba5447974, createdName=ms7000001124466419, createdTime=Tue Jul 12 23:25:37 CST 2022, time=2022-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014685, encodeId=807b101468594, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/fa7de37cae58485d98eccde049d944c8/0c35dbfa935743f99a097a3af080f677.jpeg, createdBy=059a1620547, createdName=huihui0728, createdTime=Sun Sep 05 07:12:36 CST 2021, time=2021-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012410, encodeId=481610124104f, content=这些临床常用的很有必要的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210828/3c680d82017b40f098e56a34332210c7/2c87019ea1c04c1aa7e3c8d5ea2d41b5.jpg, createdBy=69b15553885, createdName=lotus蓉, createdTime=Sat Aug 28 21:55:56 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010327, encodeId=9c6f101032eef, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/fa7de37cae58485d98eccde049d944c8/0c35dbfa935743f99a097a3af080f677.jpeg, createdBy=059a1620547, createdName=huihui0728, createdTime=Sun Aug 22 15:51:34 CST 2021, time=2021-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006895, encodeId=a05910068954b, content=收益很大, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc035513110, createdName=霍, createdTime=Wed Aug 11 10:22:34 CST 2021, time=2021-08-11, status=1, ipAttribution=)]
    2021-08-22 huihui0728

    学习一下

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1232142, encodeId=8db1123214277, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88ba5447974, createdName=ms7000001124466419, createdTime=Tue Jul 12 23:25:37 CST 2022, time=2022-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014685, encodeId=807b101468594, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/fa7de37cae58485d98eccde049d944c8/0c35dbfa935743f99a097a3af080f677.jpeg, createdBy=059a1620547, createdName=huihui0728, createdTime=Sun Sep 05 07:12:36 CST 2021, time=2021-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012410, encodeId=481610124104f, content=这些临床常用的很有必要的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210828/3c680d82017b40f098e56a34332210c7/2c87019ea1c04c1aa7e3c8d5ea2d41b5.jpg, createdBy=69b15553885, createdName=lotus蓉, createdTime=Sat Aug 28 21:55:56 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010327, encodeId=9c6f101032eef, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/fa7de37cae58485d98eccde049d944c8/0c35dbfa935743f99a097a3af080f677.jpeg, createdBy=059a1620547, createdName=huihui0728, createdTime=Sun Aug 22 15:51:34 CST 2021, time=2021-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006895, encodeId=a05910068954b, content=收益很大, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc035513110, createdName=霍, createdTime=Wed Aug 11 10:22:34 CST 2021, time=2021-08-11, status=1, ipAttribution=)]
    2021-08-11 霍

    收益很大

    0

以上为热门评论，williamhill asia 医学App还有更多内容

相关威廉亚洲博彩公司

2017年AACE/ACE血脂异常管理与动脉粥样硬化疾病预防威廉亚洲博彩公司 简介

暂未更新 · 2017-08-30

阿司匹林在动脉粥样硬化性心血管疾病中的临床应用：中国专家共识（2016）

中华医学会老年医学分会 · 2017-01-30

2型糖尿病合并动脉粥样硬化性心血管疾病患者降糖药物应用专家共识

中国内分泌相关专家小组（统称） · 2017-06-30

中国成人动脉粥样硬化性心血管疾病基层管理路径专家共识（建议稿）

中华医学会全科医学分会 · 2017-02-10

2017 AACE/ACE威廉亚洲博彩公司 ：血脂异常管理与动脉粥样硬化预防

美国临床内分泌医师学会(AACE,American Association of Clinical Endocrinologists) · 2017-02-03

2015 AHA科学声明：重度抑郁症和双相情感障碍会导致年轻人加速性动脉粥样硬化和早期心血管疾病  

美国心脏协会(AHA,American Heart Association) · 2015-08-10

拓展阅读

2015 症状性动脉粥样硬化性椎动脉起始部狭窄血管内治疗中国专家共识

中华预防医学会卒中预防与控制专业委员会介入学组 · 2015-03-17

2016 ACC专家共识：非他汀类药物降脂治疗降低动脉粥样硬化性心血管疾病风险

美国心脏病学会(ACC,American College of Cardiology) · 2016-04-03

2015 AHA科学声明：重度抑郁症和双相情感障碍会导致年轻人加速性动脉粥样硬化和早期心血管疾病  

美国心脏协会(AHA,American Heart Association) · 2015-08-10

2017 AACE/ACE威廉亚洲博彩公司 ：血脂异常管理与动脉粥样硬化预防

美国临床内分泌医师学会(AACE,American Association of Clinical Endocrinologists) · 2017-02-03

中国成人动脉粥样硬化性心血管疾病基层管理路径专家共识（建议稿）

中华医学会全科医学分会 · 2017-02-10

2型糖尿病合并动脉粥样硬化性心血管疾病患者降糖药物应用专家共识

中国内分泌相关专家小组（统称） · 2017-06-30